BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 32515466)

  • 21. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
    Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
    Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium.
    Yao Y; Chen R; Wang G; Zhang Y; Liu F
    Stem Cell Res Ther; 2019 Jul; 10(1):225. PubMed ID: 31358049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
    Wang Y; Lin C; Ren Q; Liu Y; Yang X
    Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor β1 promotes fibroblast-like synoviocytes migration and invasion via TGF-β1/Smad signaling in rheumatoid arthritis.
    Zhu D; Zhao J; Lou A; Huang Q; OuYang Q; Zhu J; Fan M; He Y; Ren H; Yang M
    Mol Cell Biochem; 2019 Sep; 459(1-2):141-150. PubMed ID: 31297660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tranilast attenuates TGF-β1-induced epithelial-mesenchymal transition in the NRK-52E cells.
    Li SS; Liu QF; He AL; Wu FR
    Pak J Pharm Sci; 2014 Jan; 27(1):51-5. PubMed ID: 24374452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smad2 and Smad3 play antagonistic roles in high glucose-induced renal tubular fibrosis via the regulation of SnoN.
    Wang Y; Zhang X; Mao Y; Liang L; Liu L; Peng W; Liu H; Xiao Y; Zhang Y; Zhang F; Shi M; Liu L; Guo B
    Exp Mol Pathol; 2020 Apr; 113():104375. PubMed ID: 31917288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of bone morphogenetic protein-7 on monocyte chemoattractant protein-1 induced epithelial-myofibroblast transition and TGF-beta1-Smad 3 signaling pathway of HKC cells].
    Tan XY; Zheng FL; Zhou QG; Duan L; Li Y
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2607-12. PubMed ID: 16321320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
    Li N; Feng F; Wu K; Zhang H; Zhang W; Wang W
    Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells.
    Zhang W; Miao J; Ma C; Han D; Zhang Y
    Peptides; 2012 Aug; 36(2):186-91. PubMed ID: 22687367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigallocatechin-3-gallate attenuates transforming growth factor-β1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells.
    Wang Y; Liu N; Su X; Zhou G; Sun G; Du F; Bian X; Wang B
    Biomed Pharmacother; 2015 Mar; 70():260-7. PubMed ID: 25776510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [1, 25-(OH)
    Huang C; Dong R; Li Z; Yuan J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):325-331. PubMed ID: 37087550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
    Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
    Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 20-Hydroxyecdysone attenuates TGF-β1-induced renal cellular fibrosis in proximal tubule cells.
    Hung TJ; Chen WM; Liu SF; Liao TN; Lee TC; Chuang LY; Guh JY; Hung CY; Hung YJ; Chen PY; Hsieh PF; Yang YL
    J Diabetes Complications; 2012; 26(6):463-9. PubMed ID: 22858168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling.
    Cai T; Sun D; Duan Y; Qiu Y; Dai C; Yang J; He W
    J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro study of TGF-β1-induced epithelial-mesenchymal transition of keloid epithelial cells].
    Yan L; Cao R; Pan B; Wang L; Lyu X; Sun X; Xiao R
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Mar; 31(2):128-33. PubMed ID: 26211188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WNT/β-catenin signal inhibitor IC-2-derived small-molecule compounds suppress TGF-β1-induced fibrogenic response of renal epithelial cells by inhibiting SMAD2/3 signalling.
    Hoi S; Tsuchiya H; Itaba N; Suzuki K; Oka H; Morimoto M; Takata T; Isomoto H; Shiota G
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):940-946. PubMed ID: 32012313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition.
    Jia L; Ma X; Gui B; Ge H; Wang L; Ou Y; Tian L; Chen Z; Duan Z; Han J; Fu R
    PLoS One; 2015; 10(2):e0117757. PubMed ID: 25679376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oleanolic acid attenuates TGF-β1-induced epithelial-mesenchymal transition in NRK-52E cells.
    He WM; Yin JQ; Cheng XD; Lu X; Ni L; Xi Y; Yin GD; Lu GY; Sun W; Wei MG
    BMC Complement Altern Med; 2018 Jul; 18(1):205. PubMed ID: 29973206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.